The relationship between estrogen and subsequent growth restriction among adolescents with heavy menstrual bleeding at menarche
article
OA: hybrid
CC0
⤵ 1 in-corpus citation
Abstract
OBJECTIVES: We sought to evaluate the impact of estrogen-containing treatment for heavy menstrual bleeding (HMB) on subsequent height compared to progesterone-only or non-hormonal treatment when initiated at menarche. METHODS: We performed a retrospective chart review of adolescent females aged 10-15 years who presented to an institution-affiliated outpatient, inpatient, or emergency setting for management of HMB within three months of menarche. Growth records over a 2 year period starting at menarche were recorded, and comparisons made among patients treated with 1) estrogen, 2) progesterone, and 3) non-hormonal methods (controls). Groups were compared using bivariate analysis with Chi-square or Fisher's exact test and linear regression. RESULTS: In an analysis of 80 patients at 24 months, the mean increase in height from menarche was 6.4 cm among controls (n=54), 7.2 cm among the progesterone-only group (n=10), and 3.8 cm among the estrogen group (n=16). The estrogen group's increase in height was significantly lower than the control group's, by a mean of 1.8 cm (p=0.04). Change in height did not differ significantly between the progesterone and control groups (p=0.87). Additionally, for every year younger at menarche, there was 1 fewer cm of growth (change in height) at 24 months after menarche (p<0.002). CONCLUSIONS: Estrogen-containing treatment for HMB initiated within three months of menarche was associated with reduced growth at 24 months compared to progesterone-only or non-hormonal methods. The clinical applicability of the estrogen group's 1.8 cm absolute reduction in height may have considerable significance for those who are shorter at baseline.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (32)
- doi:10.1097/aog.0000000000003411 via openalex
- doi:10.1677/joe.1.06059 via openalex
- doi:10.1016/j.jpag.2012.11.004 via openalex
- doi:10.1016/j.jpag.2009.11.008 via openalex
- doi:10.1359/jbmr.2002.17.4.555 via openalex
- doi:10.1159/000328126 via openalex
- doi:10.1159/000443685 via openalex
- doi:10.1016/j.jpag.2010.08.006 via openalex
- doi:10.1210/edrv.19.5.0345 via openalex
- doi:10.1002/jbmr.209 via openalex
- doi:10.1093/aje/kwi260 via openalex
- doi:10.1515/jpem-2000-s619 via openalex
- doi:10.1016/j.jpag.2015.03.001 via openalex
- doi:10.1080/00016340500342912 via openalex
- doi:10.1210/er.2002-0033 via openalex
- doi:10.1677/joe.0.1770319 via openalex
- W2911991742 via openalex
- doi:10.1016/j.jpag.2021.06.007 via openalex
- doi:10.1016/j.jpag.2018.02.130 via openalex
- doi:10.1210/er.19.5.540 via openalex
- doi:10.4274/jcrpe.galenos.2018.2018.0274 via openalex
- doi:10.1016/j.jpag.2013.12.011 via openalex
- doi:10.1159/000327788 via openalex
- doi:10.1530/joe-16-0263 via openalex
- doi:10.1210/jcem-26-11-1185 via openalex
- doi:10.1210/jc.2007-0814 via openalex
- doi:10.3346/jkms.2016.31.2.275 via openalex
- doi:10.1001/jamapediatrics.2019.5040 via openalex
- doi:10.1111/j.1651-2227.1999.tb01071.x via openalex
- doi:10.1007/s00018-013-1317-1 via openalex
- doi:10.1016/j.jpag.2018.05.002 via openalex
- doi:10.1152/ajpendo.90691.2008 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T05:16:10.622020+00:00
License: CC0
· commercial use OK